|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Noncash operating lease expense | |||||
| Unrealized and realized (gain) loss from marketable securities, net | |||||
| Noncash consideration | |||||
| Gain from step acquisition | |||||
| Other operating activities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue, current and noncurrent | |||||
| Accounts payable and accrued liabilities | |||||
| Contract liabilities | |||||
| Operating lease liabilities, current and noncurrent | |||||
| Other noncurrent liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from sales and redemption of marketable securities | |||||
| Business combinations, net of cash acquired | |||||
| Purchases of alternative investments | |||||
| Proceeds from sales of alternative investments | |||||
| Purchases of privately-held securities | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Principal payments on borrowings | |||||
| Proceeds from the exercise of common stock options | |||||
| Repurchases of common stock | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange on cash, cash equivalents, and restricted cash | |||||
| Net cash provided by (used in) financing activities | |||||
| Cash, cash equivalents, and restricted cash - beginning of period | |||||
| Cash, cash equivalents, and restricted cash - end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for income taxes | |||||
| Noncash investing and financing activities | |||||
| Accrued taxes related to net share settlement of equity awards | |||||
Loading...